Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes

Bioorg Med Chem Lett. 2021 Sep 15:48:128229. doi: 10.1016/j.bmcl.2021.128229. Epub 2021 Jun 30.

Abstract

Chronic and dysregulated cytokine signaling plays an important role in the pathogenic development of many autoimmune and inflammatory diseases. Despite intrinsic challenges in the disruption of interactions between cytokines and cytokine receptors, many first-in-class small-molecule inhibitors have been discovered over the past few years. The third part of the digest series presents recent progress in identifying such inhibitors and highlights the application of novel research tools in the fields of structural biology, computational analysis, screening methods, biophysical/biochemical assays and medicinal chemistry strategy.

Keywords: Autoimmune and inflammatory diseases; Cytokine; Cytokine receptor; Protein-protein interaction; Small molecule.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • Cytokines / antagonists & inhibitors*
  • Cytokines / immunology
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Molecular Structure
  • Receptors, Cytokine / antagonists & inhibitors*
  • Receptors, Cytokine / immunology
  • Small Molecule Libraries / chemical synthesis
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*

Substances

  • Cytokines
  • Receptors, Cytokine
  • Small Molecule Libraries